<DOC>
	<DOC>NCT00665106</DOC>
	<brief_summary>Evaluation of safety and tolerability of a single injection of NOVA63035 "Corticosteroid" administered at one of four doses in patients with diabetic macular edema (DME) secondary to diabetic retinopathy</brief_summary>
	<brief_title>Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>M &amp; F 18 years and older Diagnosed with diabetes mellitus and presenting diabetic retinopathy Monocular History of current ocular hypertension or glaucoma in either eye defined Any significant ocular disease (other than diabetic retinopathy)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Diabetic macular edema</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Diabetic retinopathy</keyword>
</DOC>